Artelo Biosciences (ARTL)
(Delayed Data from NSDQ)
$1.34 USD
-0.01 (-0.74%)
Updated Aug 2, 2024 03:58 PM ET
After-Market: $1.33 -0.01 (-0.75%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.83 |
EPS Last Quarter | -0.78 |
Last EPS Surprise | 25.71% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.09 |
Next Year | -0.98 |
EPS (TTM) | -3.16 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.83 | -0.59 | -2.09 | -0.98 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | -0.83 | -0.59 | -2.25 | -1.21 |
High Estimate | -0.83 | -0.59 | -1.93 | -0.74 |
Low Estimate | -0.83 | -0.59 | -2.25 | -1.21 |
Year ago EPS | -0.56 | -0.83 | -3.14 | -2.09 |
Year over Year Growth Est. | -48.21% | 28.92% | 33.44% | 53.35% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.83 | -0.59 | -2.09 | -0.98 |
7 Days Ago | -0.83 | -0.59 | -2.09 | -0.98 |
30 Days Ago | -0.83 | -0.59 | -2.09 | -0.98 |
60 Days Ago | -0.83 | -0.59 | -2.09 | -0.98 |
90 Days Ago | -0.74 | -0.58 | -2.07 | -1.59 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.83 | -0.59 | -2.09 | -0.98 |
Zacks Consensus Estimate | -0.83 | -0.59 | -2.09 | -0.98 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.78 | -0.99 | -0.83 | -0.56 | NA |
Estimate | -1.05 | -0.29 | -0.70 | -0.93 | NA |
Difference | 0.27 | -0.70 | -0.13 | 0.37 | -0.05 |
Surprise | 25.71% | -241.38% | -18.57% | 39.78% | -48.62% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more